Blog

  • Blog

    Massachusetts Biotech Community Calls on Congress to Fix the Small Molecule Penalty
    05.22.2023

    Given the tremendous focus of MA-based companies and investors, we had an opportunity to pen some thoughts which are shared in the attached letter.

  • Blog

    From Bad to Worse on Drug Price Controls
    05.18.2023

    The life sciences venture capital community has long warned against the adverse consequences government price controls for prescription drugs would...

  • Blog

    Incubate Celebrates World IP Day 
    04.26.2023

    In the world of Making Medicine, every day should be World IP Day.

  • Blog

    Incubate Takes the Stand: Testifying on Global Importance of IP 
    03.30.2023

    See Incubate's blog post from Executive Director John Stanford on his recent testimony before the International Trade Organization about how weakening Intellectual Property protections will damage the early-stage life science ecosystem.

  • Blog

    Mergers and Acquisitions: A Key Driver of VC Investment in Healthcare
    02.18.2021

    The drug pricing debate is a worthy one. We have to have open discussions about maximizing innovation and access. But half-written reports from a region that is home to the economic benefits of this industry do little to move that debate forward.